Capital Flow Monitor · Sponsors · CIK 1800315
Galecto, Inc.
75 State Street, Boston, MA, 02109 · (+45) 70 70 52 10
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$285.0M
Sold
$285.0M
% sold
100.0%
Investors
48
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | D ·current | 506(b) | $285.0M | $285.0M | 100.0% | 48 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Hans T. Schambye — Executive Officer / Director, Boston, MA
- Lori Firmani — Executive Officer, Boston, MA
- Garrett Winslow — Executive Officer, Boston, MA
- Carl Goldfischer — Director, Boston, MA
- Julianne Bruno — Director, Boston, MA
- Christopher Cain — Director, Boston, MA
-
Jayson Dallas — Director, Boston, MA
1 other raise
- Faeth Therapeutics, Inc. $24.4M of $25.0M · 97.7%
-
Peter Harwin — Director, Boston, MA
6 other raises
- Fairmount Healthcare Co-Invest VII L.P. $0 of —
- Fairmount Healthcare Fund II L.P. $667.0M of —
- Fairmount Healthcare Feeder Fund II L.P. $1.07B of —
- Paragon Laboratories L.P. $0 of —
- Fairmount Healthcare Co-Invest VI L.P. $0 of —
- Fairmount Healthcare Co-Invest V L.P. $0 of —
- Amit Munshi — Director, Boston, MA
Placement agents
- Ubs Securities Llc · 1 RE raises
- Jefferies Llc · 0 RE raises
- Leerink Partners Llc · 0 RE raises
- Lifesci Capital Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.